| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/28/2004 | EP1383529A2 Methods of treating disorders of the eye and surrounding tissue with thymosin 4 (t 4), analogues, isoforms and other derivatives |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383526A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/28/2004 | EP1383492A1 Molecular conjugates for use in treatment of cancer |
| 01/28/2004 | EP1383480A2 Lipid-comprising drug delivery complexes and methods for their production |
| 01/28/2004 | EP1383380A2 Fizz1 for metabolism regulation |
| 01/28/2004 | EP1194158B1 The use of the protein uk 114 for inhibiting organ transplant rejection |
| 01/28/2004 | EP1192273B1 Method for detecting mismatches or mutations in nucleic acid |
| 01/28/2004 | EP1061944B1 Therapeutic chemokine receptor antagonists |
| 01/28/2004 | EP1021528B1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 01/28/2004 | EP0974658B1 Probes for the diagnosis of infections caused by streptococcus pyogenes |
| 01/28/2004 | EP0724597B1 Ks-laminin and methods of use |
| 01/28/2004 | EP0690675B1 Nucleic acid coding for a tumor rejection antigen precursor |
| 01/28/2004 | EP0636030B1 Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471581A Human source gene guide sequence, gene carrier and gene expression method |
| 01/28/2004 | CN1471580A Virus Particles with exogenous internal eitopes |
| 01/28/2004 | CN1471579A CRIPTO tumour polypeptide |
| 01/28/2004 | CN1471576A Immortalized preosteoblasts and method for their production |
| 01/28/2004 | CN1471356A Disease-resistant plants and method of constructing the same |
| 01/28/2004 | CN1470531A Target gene entraining system using histone as core sequence |
| 01/28/2004 | CN1470529A Method for producing human serum albumin |
| 01/28/2004 | CN1470528A Snake venom enzyme nerve growth factor for treating diabetic concurrent peripheral nervous pathological complication |
| 01/28/2004 | CN1470527A Polypeptide-human calcium ion regulatory secretory action protein 48 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470526A Polypeptide-human muscle BOP protein 41 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470525A Polypeptide-human SEH protein 29 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470524A Polypeptide-human transcriptional elongation factor IIS51 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470523A Polypeptide-zinc finger protein 64 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470522A Polypeptide-XRN-100 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470521A Polypeptide-mitochondrial carrier 12 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470520A Polypeptide-zine finger protein 40 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1136314C Gene for transcription factor capable of altering characters of plants and use thereof |
| 01/28/2004 | CN1136230C Urogenital carcinoma TLP complex peptides and antibodies thereof |
| 01/28/2004 | CN1136229C Action of proinsulin associated peptide on dopamine transporter and its application in treating correlative diseases |
| 01/28/2004 | CN1136228C Casein phospho peptide, casein containing same and process for the preparation thereof |
| 01/27/2004 | US6683230 Hybrid seed production |
| 01/27/2004 | US6683210 Human t-cell leukemia/lymphoma virus, human immunodeficiency virus, and lymphadenopathy associated virus treatment |
| 01/27/2004 | US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule |
| 01/27/2004 | US6683170 Including peptides which selectively bound by targeted cell so that modified fiber protein is internalized by receptor-mediated endocytosis; trimerization |
| 01/27/2004 | US6683169 Nucleic acid encoding the human peptide histidine transporter 1 and methods of use thereof |
| 01/27/2004 | US6683168 Purified composition comprising dna molecule having specified polynucleotide sequence |
| 01/27/2004 | US6683165 Human gene relating to respiratory diseases and obesity |
| 01/27/2004 | US6683161 Human ependymin |
| 01/27/2004 | US6683160 Antibodies specific for Fkhsf gene products |
| 01/27/2004 | US6683159 Purification of antihemophilic factor; obtain antihemophilic mixture, incubate with chromatography column, elute, dilute desorbing solution, recover antihemophilic factor |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683157 Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof |
| 01/27/2004 | US6683155 Purified and isolated polypeptide comprising specified amino acid sequence; regulating degradation of extracellular matrix |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6683058 Methods for therapy of neurodegenerative disease of the brain |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683052 Lipopeptides containing an interferon-γ fragment, and uses thereof in pharmaceutical compositions |
| 01/27/2004 | US6683050 Compounds with anti-KS and anti-HIV activity |
| 01/27/2004 | US6683049 Relieving pain from neuromuscular disorders using botulinum toxins |
| 01/27/2004 | US6683048 Compounds and methods for stimulating gene expression and cellular differentiation |
| 01/27/2004 | US6683047 Method of inhibiting transcription utilizing nuclear receptors |
| 01/27/2004 | US6683046 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
| 01/27/2004 | US6682928 Cell is transformed to express on its surface a component which binds to an fc receptor of an effector cell used as a vehicle to increase an cell lysis and phagocytosis against an antigen associated with the cell |
| 01/27/2004 | US6682921 Useful for solving the crystal and solution structures of the tyrosine kinase domains and for identifying compounds that bind to domains of receptor and non-receptor tyrosine kinases |
| 01/27/2004 | US6682911 Laminins and uses thereof |
| 01/27/2004 | US6682910 Gene expression, incubation; genetic engineering |
| 01/27/2004 | US6682909 Polypeptide for use in the diagnosis, treatment and prevention of hepatitis infections |
| 01/27/2004 | US6682908 Mouse growth hormone secretagogue receptor |
| 01/27/2004 | US6682907 Lentivirus have the unique capacity among retroviruses of infecting differentiated non mitotic cells and represent viral candidates of interest for the development of novel vectors |
| 01/27/2004 | US6682905 Receptor-type phosphotyrosine phosphatase-alpha |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682901 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding |
| 01/27/2004 | US6682898 Analyzing using phosphated tyrosine compound |
| 01/27/2004 | US6682897 Peptides derived from human heat protein 60 for treatment of diabetes, compositions, methods and kits |
| 01/27/2004 | US6682896 Isolated polyclonal antibody having neutralizing binding affinity for said peptides; diagnostic or prognostic assay where patient receiving ifn-beta therapy can be assessed for production of ifn-beta neutralizing antibodies |
| 01/27/2004 | US6682894 Screening for preferential immunoglobulin; obtain human immunoglobulin receptor segment, incubate with antigen, detect complex formation |
| 01/27/2004 | US6682886 Bivalent binding molecules of 7 transmembrane G protein-coupled receptors |
| 01/27/2004 | US6682760 Cross-linked collagen matrices and methods for their preparation |
| 01/27/2004 | US6682744 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 01/27/2004 | US6682742 Vector for integration of heterologous sequences into poxviral genomes |
| 01/27/2004 | US6682741 Vaccination and tumor therapy |
| 01/27/2004 | US6682740 Peptides derived fram complement peptide C3a sequence and antiallergic compositions comprising them |
| 01/27/2004 | US6682738 Inducing expansion or stress relaxation |
| 01/27/2004 | US6682737 Monoclonal antibody having the same or overlapping epitope binding specificity as that of 3e2 secreted by hybridoma atcc hb 12075 |
| 01/27/2004 | US6682731 Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules |
| 01/27/2004 | CA2140663C Compounds which inhibit hiv replication |
| 01/27/2004 | CA2080428C A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004008148A1 Method for detection of bioactive peptides |
| 01/22/2004 | WO2004008141A1 Novel screening method |
| 01/22/2004 | WO2004008103A2 Mutations of voltage-gated potassium channels |
| 01/22/2004 | WO2004008102A2 Liver tumor marker sequences |
| 01/22/2004 | WO2004008099A2 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 01/22/2004 | WO2004007753A2 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 01/22/2004 | WO2004007747A2 Assays for assembly of ebola virus nucleocapsids |
| 01/22/2004 | WO2004007740A1 Biological method for producing t-20 peptide |
| 01/22/2004 | WO2004007733A1 Transgenic expression constructs and methods for increasing the vitamin e content in plant organisms |
| 01/22/2004 | WO2004007731A1 Transgenic expression constructs and methods for increasing the vitamin e content in plant organisms |
| 01/22/2004 | WO2004007729A1 Transcriptional control element, chimeric constructs and uses therefor |
| 01/22/2004 | WO2004007727A1 Use of a gene for increasing the oil content in plants |
| 01/22/2004 | WO2004007726A2 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | WO2004007725A1 Polypeptide of streptococcus pyogenes |
| 01/22/2004 | WO2004007724A1 Method of transporting protein to mitochondria |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007722A2 Transgenic animal expressing alzheimer’s tau protein |